PDCD1 and breast carcinoma: Five patients with advanced gastrointestinal tumors (2 gastric cancers, 1 esophageal cancer, 1 colorectal cancer, and 1 breast cancer) who previously failed anti–PD-1 monotherapy completed in this study.